Pain Management
Implementing ICU Liberation Bundle benefits mechanically ventilated patients
Among mechanically ventilated patients, implementation of the ICU Liberation Bundle meant shorter ICU stays and less time receiving ventilation, according to study results published in Critical Care Explorations.
FDA grants breakthrough therapy designation to opioid with ‘overdose protection’
The FDA has granted breakthrough therapy designation to PF614-MPAR, a “next-generation opioid” designed to limit oral overdose potential, according to a press release from its manufacturer.
FDA approves Indocin oral suspension generic for inflammatory conditions
The FDA has approved an abbreviated new drug application from ANI Pharmaceuticals for indomethacin oral suspension, a generic version of Indocin oral suspension, according to a press release from the manufacturer.
Social determinants of health play ‘an important role’ in end-of-life pain strategies
Patients with gastrointestinal cancers face ongoing racial/ethnicity-based disparities in end-of-life pain management, specifically in terms of access to and utilization of opioids, study results showed.
The year in pain: Healio’s top 2023 stories on opioids, chronic pain myths and management
The state of pain management in rheumatology has always been in flux.
New WHO guidance on lower back pain advises against TENS, lumbar support
WHO recently released recommendations on managing chronic low back pain in primary care — the organization’s first ever guidelines on the subject.
Odds of opioid use in autoimmune rheumatic disease decreased 15% annually after 2014
SAN DIEGO — The likelihood of opioid use among patients with autoimmune rheumatic disease has decreased annually by 15% since 2014, according to data presented at ACR Convergence 2023.
VIDEO: Microbiome still holds ‘more questions than answers’ for autoimmune disease
In a Healio video exclusive, Leonard Calabrese, DO, chief medical editor of Healio Rheumatology, offered his insights for our November issue, led by a cover story examining the connection between the gut microbiome and rheumatic disease.
One in four adults use pharmacologic therapies for chronic pain
One in four adults relied solely on medications to manage chronic pain, highlighting an opportunity to increase use of nonpharmacologic therapies, particularly in men, older adults and those with public insurance, according to researchers.
Surveys show providers and patients increasingly endorse ‘whole-person’ integrative care
It has taken decades, but with each passing year, integrative health care is marching more squarely into the mainstream of American medicine.